Kerala firm successfully completes Phase 2 trials of Covid drug
By IANS |
Published on
Thu, Feb 11 2021 22:57 IST |
0 Views
Despite the widespread use of oral contraceptives (OCPs) by women, many are not aware that it may impair their ability to recognise others emotional expressions, which may have serious consequences in interpersonal contexts, suggests a new study.. Image Source: IANS News
Kochi, Feb 11 : PNB Vesper, a leading Kerala-based life sciences company, on Thursday announced that it has successfully completed the Phase 2 clinical trials of its proprietary drug PNB-001 (GPP-Baladol) on Covid-19 patients.
The company had received approval from the Drug Controller General of India (DCGI) to conduct the Phase 2 trial on patients with moderate Covid and on oxygen support in September 2020.